Has the mortality rate from acute myocardial infarction fallen substantially in recent years?

European Heart Journal

Volumn 23, Issue 9, 2002, Pages 689-692

  Wong, C K ^a   White, H D ^a  

^a GREEN LANE HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ACUTE HEART INFARCTION; CLINICAL PRACTICE; EDITORIAL; EVIDENCE BASED MEDICINE; FIBRINOLYTIC THERAPY; HEART ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HUMAN; MORTALITY; PRIORITY JOURNAL;

HOSPITAL MORTALITY; HUMANS; LENGTH OF STAY; MYOCARDIAL INFARCTION; REGISTRIES; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 0036558699     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.2001.3054     Document Type: Editorial

References (20)

1. Zoll PM, Linethal AJ, Gibson W, Paul MH, Norman LR. Termination of ventricular fibrillation in man by externally applied countershock. N Engl J Med 1956; 254: 727-32.
2. Kowenhouven WB, Jude JR, Knickerbocker GG. Closed chest cardiac massage. JAMA 1960; 173: 1064-7.
3. Lown B, Fakhro AM, Hood WB Jr, Thorn GW. The coronary care unit: New perspectives and directions. JAMA 1967; 199: 188-98.
4. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994; 343: 311-22.
5. The Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 Investigators. Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: The ASSENT-3 randomised trial in acute myocardial infarction. Lancet 2001; 358: 605-13.
6. The GUSTO V Investigators. Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: The GUSTO V Randomized Trial. Lancet 2001; 357: 1905-14.
7. Chambless L, Keil U, Dobson A et al. Population versus clinical view of case fatality from acute coronary heart disease: results from the WHO MONICA Project 1985-1990. Circulation 1997; 96: 3849-59.
8. Norris RM, on behalf of the United Kingdom Heart Attack Study Collaborative Group. Fatality outside hospital from acute coronary events in three British health districts, 1994-5. Br Med J 1998; 316: 1065-70.
9. Kuch B, Bolte HD, Hoermann A, Meisinger C, Loewel H. What is the real hospital mortality from acute myocardial infarction? Epidemiological vs clinical view. Eur Heart J 2002; 23: 715-21.
10. Rogers WJ, Canto JG, Lambrew CT et al. Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999: The National Registry of Myocardial Infarction 1, 2 and 3. J Am Coll Cardiol 2000; 36: 2056-63.
11. Marciniak TA, Ellerbeck EF, Radford MJ et al. Improving the quality of care for Medicare patients with acute myocardial infarction: Results from the Cooperative Cardiovascular Project. JAMA 1998; 279: 1351-7.
12. Fox KAA, Goodman SG, Klein W, Brieger D, Steg PG, Dabbous O, Avezum A, for the GRACE Investigators. Management of acute coronary syndromes: Variations in practice and outcome: Findings from Global Registry of Acute Coronary Events. Eur Heart J 2002 (in press).
13. The Hirulog and Early Reperfusion or Occlusion (HERO)-2 Trial Investigators. Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction: The HERO-2 randomised trial. Lancet 2001; 358: 1855-63.
14. Kannel WB, Abbott RD. Incidence and prognosis of unrecognized myocardial infarction: An update on the Framingham Study. N Engl J Med 1984; 311: 1144-7.
15. Collinson J, Flather MD, Fox KA et al. Clinical outcomes, risk stratification and practice patterns of unstable angina and myocardial infarction without ST elevation: Prospective Registry of Acute Ischaemic Syndromes in the UK (PRAIS-UK). Eur Heart J 2000; 21: 1450-7.
16. Dorsch MF, Lawrance RA, Sapsford RJ et al. Poor prognosis of patients presenting with symptomatic myocardial infarction but without chest pain. Heart 2001; 86: 494-8.
17. Wong C-K, White HD. Recognising "painless" heart attacks [editorial]. Heart 2002; 87: 3-5.
18. WHO MONICA Project. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project: Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 1994; 90: 583-612.
19. Goldberg RJ, Gore JM, Gurwitz JH et al. The impact of age on the incidence and prognosis of initial acute myocardial infarction: The Worcester Heart Attack Study. Am Heart J 1989; 117: 543-9.
20. Holmes-Rovner M, Llewellyn-Thomas H, Entwistle V, Coulter A, O'Connor A, Rovner DR. Patient choice modules for summaries of clinical effectiveness: a proposal. Br Med J 2001; 322: 664-7.